AI assistant
IONIS PHARMACEUTICALS INC — Director's Dealing 2014
Oct 3, 2014
30591_dirs_2014-10-03_d2df5c0a-554a-4af3-8845-87d18d872d88.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2014-10-01
Reporting Person: O'NEIL PATRICK R. (SVP, Legal & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-10-01 | Common Stock | M | 233 | $10.29 | Acquired | 3986 | Direct |
| 2014-10-01 | Common Stock | S | 233 | $38.20 | Disposed | 3753 | Direct |
| 2014-10-01 | Common Stock | M | 467 | $7.25 | Acquired | 4220 | Direct |
| 2014-10-01 | Common Stock | S | 467 | $38.20 | Disposed | 3753 | Direct |
| 2014-10-01 | Common Stock | M | 800 | $7.25 | Acquired | 4553 | Direct |
| 2014-10-01 | Common Stock | S | 800 | $37.90 | Disposed | 3753 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-10-01 | Employee Stock Option (right to buy) | $10.29 | M | 233 | Disposed | 2018-01-02 | Common Stock (233) | Direct |
| 2014-10-01 | Employee Stock Option (right to buy) | $7.25 | M | 1267 | Disposed | 2019-01-02 | Common Stock (1267) | Direct |
Footnotes
F1: Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 1/2/2014.
F2: Grant of 1/3/2011 to reporting person of stock options under the Isis Pharmacueticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/3/2012. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 5,750 shares per year. Following this transaction, the option was exercisable as to 3,833 on 10/1/2014.
F3: Grant of 1/3/2012 to reporting person of stock options under the Isis Pharmacueticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/3/2013. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 4,875 shares per year. Following this transaction, the option was exercisable as to 6,533 on 10/1/2014.